We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Barnes & Noble Education
BNED
$431M
| $764K | ﹤0.01% |
797
+209
| +36% | +$213K |
|
2052
First Bancorp
FBNC
$2.6B
| $763K | ﹤0.01% |
26,053
+726
| +3% | +$21.2K |
|
|
SP
2053
DELISTED
SP Plus Corporation
SP
| $763K | ﹤0.01% |
22,597
+436
| +2% | +$13.3K |
|
2054
American Public Education
APEI
$890M
| $761K | ﹤0.01% |
33,216
+8,892
| +37% | +$207K |
|
2055
Modine Manufacturing
MOD
$10.7B
| $761K | ﹤0.01% |
62,362
+1,893
| +3% | +$23.5K |
|
|
LMOS
2056
DELISTED
Lumos Networks Corp
LMOS
| $760K | ﹤0.01% |
42,914
+12,883
| +43% | +$215K |
|
2057
Myers Industries
MYE
$1.29B
| $759K | ﹤0.01% |
47,872
+12,226
| +34% | +$174K |
|
2058
Unitil
UTL
$970M
| $757K | ﹤0.01% |
16,811
+776
| +5% | +$34.9K |
|
|
ISLE
2059
DELISTED
Isle of Capri Casinos Inc
ISLE
| $754K | ﹤0.01% |
28,593
+1,078
| +4% | +$26.7K |
|
2060
Enova International
ENVA
$6.33B
| $753K | ﹤0.01% |
50,683
+12,906
| +34% | +$182K |
|
2061
Ingles Markets
IMKTA
$1.71B
| $752K | ﹤0.01% |
17,417
+515
| +3% | +$23.7K |
|
2062
First Financial Corp
THFF
$958M
| $752K | ﹤0.01% |
15,836
-210
| -1% | -$10.1K |
|
|
GLOG
2063
DELISTED
GASLOG LTD
GLOG
| $749K | ﹤0.01% |
48,795
+1,417
| +3% | +$22.7K |
|
|
LADR
2064
Ladder Capital
LADR
$1.21B
| $747K | ﹤0.01% |
51,747
+5,731
| +12% | +$80.7K |
|
|
ICON
2065
DELISTED
Iconix Brand Group, Inc.
ICON
| $745K | ﹤0.01% |
9,907
+3,021
| +44% | +$266K |
|
2066
MGP Ingredients
MGPI
$379M
| $744K | ﹤0.01% |
13,717
+515
| +4% | +$24.3K |
|
|
TESO
2067
DELISTED
Tesco Corp
TESO
| $742K | ﹤0.01% |
92,207
+26,111
| +40% | +$221K |
|
2068
Camden National
CAC
$978M
| $741K | ﹤0.01% |
16,828
+610
| +4% | +$25.9K |
|
|
ARII
2069
DELISTED
American Railcar Industries, Inc.
ARII
| $741K | ﹤0.01% |
18,035
-57
| -0.3% | -$2.51K |
|
2070
Middlesex Water
MSEX
$1.07B
| $740K | ﹤0.01% |
20,014
+669
| +3% | +$25K |
|
2071
Great Southern Bancorp
GSBC
$874M
| $739K | ﹤0.01% |
14,641
+500
| +4% | +$25.4K |
|
|
GHDX
2072
DELISTED
Genomic Health, Inc.
GHDX
| $736K | ﹤0.01% |
23,368
+502
| +2% | +$14.9K |
|
2073
BioCryst Pharmaceuticals
BCRX
$2.28B
| $735K | ﹤0.01% |
87,468
+2,740
| +3% | +$19.1K |
|
|
LOXO
2074
DELISTED
Loxo Oncology, Inc
LOXO
| $731K | ﹤0.01% |
17,366
+3,118
| +22% | +$128K |
|
|
CWEN.A
2075
DELISTED
Clearway Energy Class A
CWEN.A
| $729K | ﹤0.01% |
41,912
+2,464
| +6% | +$40.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.